Evidence map›Paper›PMID 24489934›Full record

ArticlePloS one2014

IKK2 inhibition attenuates laser-induced choroidal neovascularization.

Huayi Lu, Qingxian Lu, Subhash Gaddipati, Ramesh Babu Kasetti, Wei Wang, Manolis Pasparakis, Henry J Kaplan, Qiutang Li

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Huayi LuDepartments of Ophthalmology and Visual Sciences, University of Louisville School of Medicine, Louisville, Kentucky, United States of America ; Second Hospital of Jilin University, Changchun, Jilin Province, P.R. China.
Qingxian LuDepartments of Ophthalmology and Visual Sciences, University of Louisville School of Medicine, Louisville, Kentucky, United States of America ; James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, Kentucky, United States of America.
Subhash GaddipatiDepartments of Ophthalmology and Visual Sciences, University of Louisville School of Medicine, Louisville, Kentucky, United States of America ; James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, Kentucky, United States of America.
Ramesh Babu KasettiDepartments of Ophthalmology and Visual Sciences, University of Louisville School of Medicine, Louisville, Kentucky, United States of America.
Wei WangDepartments of Ophthalmology and Visual Sciences, University of Louisville School of Medicine, Louisville, Kentucky, United States of America.
Manolis PasparakisInstitute for Genetics, University of Cologne, Cologne, Germany.
Henry J KaplanDepartments of Ophthalmology and Visual Sciences, University of Louisville School of Medicine, Louisville, Kentucky, United States of America.
Qiutang LiDepartments of Ophthalmology and Visual Sciences, University of Louisville School of Medicine, Louisville, Kentucky, United States of America ; James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, Kentucky, United States of America.
University of Louisville · USUniversity of Cologne · DE

Funding

Role of 14-3-3o in development and repair of corneal epitheliumR01EY019891 · NEI · UNIVERSITY OF LOUISVILLE · PI LI, QIUTANG · 2010 to 2013
$1.4M
14-3-3?? and epithelial differentiation in the eye and other tissuesR21EY021584 · NEI · UNIVERSITY OF LOUISVILLE · PI LI, QIUTANG · 2011 to 2012
$411k
NEI NIH HHS EY019891NEI NIH HHS EY021584NEI NIH HHS R01 EY019891NEI NIH HHS R21 EY021584
6 · The paper itself

Abstract

Choroidal neovascularization (CNV) is aberrant angiogenesis associated with exudative age-related macular degeneration (AMD), a leading cause of blindness in the elderly. Inflammation has been suggested as a risk factor for AMD. The IKK2/NF-κB pathway plays a key role in the inflammatory response through regulation of the transcription of cytokines, chemokines, growth factors and angiogenic factors. We investigated the functional role of IKK2 in development of the laser-induced CNV using either Ikk2 conditional knockout mice or an IKK2 inhibitor. The retinal neuronal tissue and RPE deletion of IKK2 was generated by breeding Ikk2(-/flox) mice with Nestin-Cre mice. Deletion of Ikk2 in the retina caused no obvious defect in retinal development or function, but resulted in a significant reduction in laser-induced CNV. In addition, intravitreal or retrobulbar injection of an IKK2 specific chemical inhibitor, TPCA-1, also showed similar inhibition of CNV. Furthermore, in vitro inhibition of IKK2 in ARPE-19 cells significantly reduced heat shock-induced expression of NFKBIA, IL1B, CCL2, VEGFA, PDGFA, HIF1A, and MMP-2, suggesting that IKK2 may regulate multiple molecular pathways involved in laser-induced CNV. The in vivo laser-induced expression of VEGFA, and HIF1A in RPE and choroidal tissue was also blocked by TPCA-1 treatment. Thus, IKK2/NF-κB signaling appears responsible for production of pro-inflammatory and pro-angiogenic factors in laser-induced CNV, suggesting that this intracellular pathway may serve as an important therapeutic target for aberrant angiogenesis in exudative AMD.

Indexed as

AnimalsChoroidal NeovascularizationI-kappa B KinaseLasersMiceMice, KnockoutNF-kappa BSignal TransductionI-kappa B KinaseIkbkb protein, mouseNF-kappa B

Identifiers

PMID24489934
PMCPMC3905033
OpenAlexW2060357236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.